T1	Participants 551 786	Six HIV-seropositive subjects with elevated amounts of TNF-alpha in plasma at least at two occasions were included in an open, controlled, randomized, cross-over study consisting of a 6 week treatment period and a 6 week control period
T2	Participants 501 549	HIV-seropositive persons with elevated TNF-alpha
